business

Guggenheim Initiates Coverage Of Opus Genetics (IRD) With “Buy” Rating And $16 Price Target

Yahoo Finance · Jun 10, 2026, 6:22 PM · Also reported by 4 other sources

Read full story on Yahoo Finance → More top stories

Also covered by

Investing.com KeyBanc initiates Phinia stock coverage with overweight rating Investing.com RBC Capital initiates Natera stock coverage with outperform rating Investing.com Stifel initiates Oric Pharmaceuticals stock with buy rating Investing.com Evercore ISI initiates Octave Intelligence stock with In Line rating

Aggregated and edited by the Scoop newsroom. We surface news from Yahoo Finance alongside other reporting so you can compare coverage in one place. Editorial policy · Corrections · About Scoop

Guggenheim Initiates Coverage Of Opus Genetics (IRD) With “Buy” Rating And $16 Price Target

Also covered by

More in business